Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LYR motif-containing protein 2 (LYRM2) is a small, basic mitochondrial protein categorized within the LYR motif protein family, which is defined by a conserved Leu-Tyr-Arg (LYR) sequence near the N-terminus[2][3][1]. LYRM2 is involved in the assembly or regulation of mitochondrial complex I, a central enzyme in the mitochondrial respiratory chain and oxidative phosphorylation[5]. The loss or dysfunction of LYRM proteins can impact mitochondrial metabolism and has been linked to various disorders associated with mitochondrial dysfunction[1][3]. Although the exact function of LYRM2 is not fully defined, it is thought to affect complex I assembly indirectly, and there are indications it may play a role in DNA repair in higher eukaryotes[2]. LYRM2 has been associated with X-linked sideroblastic anemia with ataxia in humans[3]. Recent research suggests possible involvement in cancer through modulation of a signaling axis with Akt and complex I, highlighting potential relevance to tumor growth, but there is still no evidence of direct drug interactions or its use as a therapeutic target[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LYR motif-containing protein 2 (LYRM2).